{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:19:19Z","timestamp":1783077559364,"version":"3.54.6"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04093-8","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:54:49Z","timestamp":1763981689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Amino acid metabolic reprogramming drives pathogenesis and therapy in hematologic malignancies"],"prefix":"10.1007","volume":"16","author":[{"given":"Dexiang","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"26","key":"4093_CR1","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1182\/blood.2023020078","volume":"142","author":"RP Hasserjian","year":"2023","unstructured":"Hasserjian RP, Germing U, Malcovati L. Diagnosis and classification of myelodysplastic syndromes . Blood. 2023;142(26):2247\u201357. https:\/\/doi.org\/10.1182\/blood.2023020078.","journal-title":"Blood"},{"issue":"7","key":"4093_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","volume":"21","author":"AE Whiteley","year":"2021","unstructured":"Whiteley AE, Price TT, Cantelli G, et al. Leukaemia: a model metastatic disease . Nat Rev Cancer. 2021;21(7):461\u201375. https:\/\/doi.org\/10.1038\/s41568-021-00355-z.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4093_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022 . J Natl Cancer Cent. 2024;4(1):47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent"},{"issue":"7","key":"4093_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ccell.2021.06.003","volume":"39","author":"SK Joshi","year":"2021","unstructured":"Joshi SK, Nechiporuk T, Bottomly D, et al. The AML microenvironment catalyzes a Stepwise evolution to gilteritinib resistance . Cancer Cell. 2021;39(7):999\u2013e10148. https:\/\/doi.org\/10.1016\/j.ccell.2021.06.003.","journal-title":"Cancer Cell"},{"issue":"7","key":"4093_CR5","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2174\/0929867327666200207114658","volume":"28","author":"P Stepka","year":"2021","unstructured":"Stepka P, Vsiansky V, Raudenska M, et al. Metabolic and amino acid alterations of the tumor microenvironment . Curr Med Chem. 2021;28(7):1270\u201389. https:\/\/doi.org\/10.2174\/0929867327666200207114658.","journal-title":"Curr Med Chem"},{"issue":"1","key":"4093_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, et al. Amino acids in cancer . Exp Mol Med. 2020;52(1):15\u201330. https:\/\/doi.org\/10.1038\/s12276-020-0375-3.","journal-title":"Exp Mol Med"},{"issue":"491","key":"4093_CR7","doi-asserted-by":"publisher","first-page":"eaau1167","DOI":"10.1126\/scitranslmed.aau1167","volume":"11","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yao Y, Zhang S, et al. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma . Sci Transl Med. 2019;11(491):eaau1167. https:\/\/doi.org\/10.1126\/scitranslmed.aau1167.","journal-title":"Sci Transl Med"},{"issue":"7","key":"4093_CR8","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/ijc.31170","volume":"142","author":"C De Santo","year":"2018","unstructured":"De Santo C, Booth S, Vardon A, et al. The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100 . Int J Cancer. 2018;142(7):1490\u2013502. https:\/\/doi.org\/10.1002\/ijc.31170.","journal-title":"Int J Cancer"},{"issue":"7","key":"4093_CR9","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1038\/cddis.2012.83","volume":"3","author":"B Delage","year":"2012","unstructured":"Delage B, Luong P, Maharaj L, et al. Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis . Cell Death Dis. 2012;3(7):e342. https:\/\/doi.org\/10.1038\/cddis.2012.83.","journal-title":"Cell Death Dis"},{"key":"4093_CR10","doi-asserted-by":"publisher","first-page":"651687","DOI":"10.3389\/fimmu.2021.651687","volume":"12","author":"G Wells","year":"2021","unstructured":"Wells G, kennedy PT, dahal LN. Investigating the role of indoleamine 2,3-Dioxygenase in acute myeloid leukemia: A systematic review . Front Immunol. 2021;12:651687. https:\/\/doi.org\/10.3389\/fimmu.2021.651687.","journal-title":"Front Immunol"},{"issue":"11","key":"4093_CR11","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/s41401-023-01108-4","volume":"44","author":"Z-J Zhang","year":"2023","unstructured":"Zhang Z-J, Wu Q-F, Ren A-Q, et al. ATF4 renders human T-cell acute lymphoblastic leukemia cell resistance to FGFR1 inhibitors through amino acid metabolic reprogramming . Acta Pharmacol Sin. 2023;44(11):2282\u201395. https:\/\/doi.org\/10.1038\/s41401-023-01108-4.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"4093_CR12","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.clnu.2023.06.011","volume":"42","author":"H Qiu","year":"2023","unstructured":"Qiu H, Shao N, Liu J, et al. Amino acid metabolism in tumor: new shine in the fog? . Clin Nutr. 2023;42(8):1521\u201330. https:\/\/doi.org\/10.1016\/j.clnu.2023.06.011.","journal-title":"Clin Nutr"},{"issue":"2","key":"4093_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.4049\/jimmunol.0903586","volume":"185","author":"EL Carr","year":"2010","unstructured":"Carr EL, Kelman A, Wu GS, et al. Glutamine uptake and metabolism are coordinately regulated by ERK\/MAPK during T lymphocyte activation . J Immunol. 2010;185(2):1037\u201344. https:\/\/doi.org\/10.4049\/jimmunol.0903586.","journal-title":"J Immunol"},{"issue":"1","key":"4093_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s42003-024-06453-6","volume":"7","author":"C Sauter","year":"2024","unstructured":"Sauter C, Morin T, Guidez F, Et. Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia . Commun Biology. 2024;7(1):753. https:\/\/doi.org\/10.1038\/s42003-024-06453-6.","journal-title":"Commun Biology"},{"issue":"6","key":"4093_CR15","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3324\/haematol.2022.281538","volume":"108","author":"L Li","year":"2023","unstructured":"Li L, Nie L, Jordan A, et al. Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma . Haematologica. 2023;108(6):1616\u201327. https:\/\/doi.org\/10.3324\/haematol.2022.281538.","journal-title":"Haematologica"},{"issue":"1","key":"4093_CR16","doi-asserted-by":"publisher","first-page":"20220602","DOI":"10.1515\/med-2022-0602","volume":"18","author":"W Zhang","year":"2023","unstructured":"Zhang W, Liu B, Wu S, et al. TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia . Open Med (Wars). 2023;18(1):20220602. https:\/\/doi.org\/10.1515\/med-2022-0602.","journal-title":"Open Med (Wars)"},{"issue":"3","key":"4093_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bjh.18884","volume":"202","author":"Z Ma","year":"2023","unstructured":"Ma Z, Ye W, Wang J, et al. Glutamate dehydrogenase 1: A novel metabolic target in inhibiting acute myeloid leukaemia progression . Br J Haematol. 2023;202(3):566\u201377. https:\/\/doi.org\/10.1111\/bjh.18884.","journal-title":"Br J Haematol"},{"issue":"11","key":"4093_CR18","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1158\/1535-7163.MCT-21-0071","volume":"20","author":"ME Zavorka Thomas","year":"2021","unstructured":"Zavorka Thomas ME, Lu X, Talebi Z, et al. Gilteritinib inhibits glutamine uptake and utilization in FLT3-ITD-Positive AML . Mol Cancer Ther. 2021;20(11):2207\u201317. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0071.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"4093_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1182\/blood.2021013201","volume":"139","author":"ML Amaya","year":"2022","unstructured":"Amaya ML, Inguva A, Pei S, et al. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation . Blood. 2022;139(4):584\u201396. https:\/\/doi.org\/10.1182\/blood.2021013201.","journal-title":"Blood"},{"issue":"5","key":"4093_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","volume":"40","author":"M Nakaya","year":"2014","unstructured":"Nakaya M, Xiao Y, Zhou X, et al. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation . Immunity. 2014;40(5):692\u2013705. https:\/\/doi.org\/10.1016\/j.immuni.2014.04.007.","journal-title":"Immunity"},{"issue":"6","key":"4093_CR21","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/hep.27717","volume":"61","author":"C Tsien","year":"2015","unstructured":"Tsien C, Davuluri G, Singh D, et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis . Hepatology. 2015;61(6):2018\u201329. https:\/\/doi.org\/10.1002\/hep.27717.","journal-title":"Hepatology"},{"issue":"396","key":"4093_CR22","doi-asserted-by":"publisher","first-page":"ra97","DOI":"10.1126\/scisignal.aab2610","volume":"8","author":"D Klysz","year":"2015","unstructured":"Klysz D, Tai X, Robert PA, et al. Glutamine-dependent \u03b1-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation . Sci Signal. 2015;8(396):ra97. https:\/\/doi.org\/10.1126\/scisignal.aab2610.","journal-title":"Sci Signal"},{"key":"4093_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coi.2014.01.006","volume":"27","author":"JA Maciolek","year":"2014","unstructured":"Maciolek JA, Pasternak JA, Wilson HL. Metabolism of activated T lymphocytes . Curr Opin Immunol. 2014;27:60\u201374. https:\/\/doi.org\/10.1016\/j.coi.2014.01.006.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"4093_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00280-017-3459-6","volume":"81","author":"A Emadi","year":"2018","unstructured":"Emadi A, Law JY, Strovel ET, et al. Asparaginase erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed\/refractory acute myeloid leukemia . Cancer Chemother Pharmacol. 2018;81(1):217\u201322. https:\/\/doi.org\/10.1007\/s00280-017-3459-6.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"4093_CR25","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1158\/0008-5472.CAN-12-4402","volume":"73","author":"EA Ehsanipour","year":"2013","unstructured":"Ehsanipour EA, Sheng X, Behan JW, et al. Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine . Cancer Res. 2013;73(10):2998\u20133006. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4402.","journal-title":"Cancer Res"},{"issue":"10","key":"4093_CR26","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1182\/blood.2019004500","volume":"136","author":"L Fultang","year":"2020","unstructured":"Fultang L, Booth S, Yogev O, et al. Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity . Blood. 2020;136(10):1155\u201360. https:\/\/doi.org\/10.1182\/blood.2019004500.","journal-title":"Blood"},{"issue":"1","key":"4093_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12863-021-01022-w","volume":"23","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Wang H, Liao P, et al. Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker . BMC Genom Data. 2022;23(1):7. https:\/\/doi.org\/10.1186\/s12863-021-01022-w.","journal-title":"BMC Genom Data"},{"issue":"5","key":"4093_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","volume":"122","author":"F Mussai","year":"2013","unstructured":"Mussai F, de Santo C, Abu-Dayyeh I, et al. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment . Blood. 2013;122(5):749\u201358. https:\/\/doi.org\/10.1182\/blood-2013-01-480129.","journal-title":"Blood"},{"issue":"41","key":"4093_CR29","doi-asserted-by":"publisher","first-page":"67333","DOI":"10.18632\/oncotarget.12024","volume":"7","author":"A Romano","year":"2016","unstructured":"Romano A, Parrinello NL, Vetro C, et al. The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic hodgkin lymphoma . Oncotarget. 2016;7(41):67333\u201346. https:\/\/doi.org\/10.18632\/oncotarget.12024.","journal-title":"Oncotarget"},{"issue":"3","key":"4093_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00262-022-03268-4","volume":"72","author":"V Stavrou","year":"2023","unstructured":"Stavrou V, Fultang L, Booth S, et al. Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment . Cancer Immunol Immunother. 2023;72(3):543\u201360. https:\/\/doi.org\/10.1007\/s00262-022-03268-4.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"4093_CR31","doi-asserted-by":"publisher","first-page":"e2201409","DOI":"10.1002\/smtd.202201409","volume":"7","author":"S Jia","year":"2023","unstructured":"Jia S, Ji S, Zhao J, et al. A fluorinated supramolecular Self-Assembled peptide as nanovaccine adjuvant for enhanced cancer vaccine therapy . Small Methods. 2023;7(5):e2201409. https:\/\/doi.org\/10.1002\/smtd.202201409.","journal-title":"Small Methods"},{"issue":"1","key":"4093_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","volume":"30","author":"L Han","year":"2023","unstructured":"Han L, Dong L, Leung K, et al. METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism . Cell Stem Cell. 2023;30(1):52\u2013e6813. https:\/\/doi.org\/10.1016\/j.stem.2022.12.006.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4093_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Cui L, Lu S, et al. Amino acid metabolism in tumor biology and therapy . Cell Death Dis. 2024;15(1):42. https:\/\/doi.org\/10.1038\/s41419-024-06435-w.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4093_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10735-023-10170-5","volume":"55","author":"Y Wang","year":"2024","unstructured":"Wang Y, Tong H, Wang J, et al. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating \u03b2-catenin\/c-Myc signaling . J Mol Histol. 2024;55(1):37\u201350. https:\/\/doi.org\/10.1007\/s10735-023-10170-5.","journal-title":"J Mol Histol"},{"issue":"11","key":"4093_CR35","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3390\/ph14111070","volume":"14","author":"EV Lukasheva","year":"2021","unstructured":"Lukasheva EV, Babayeva G, Karshieva SS, et al. L-Lysine \u03b1-Oxidase: enzyme with anticancer properties . Pharmaceuticals (Basel). 2021;14(11):1070. https:\/\/doi.org\/10.3390\/ph14111070.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"4093_CR36","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.3390\/ijms22126321","volume":"22","author":"P Karagianni","year":"2021","unstructured":"Karagianni P, Giannouli S, And Voulgarelis M. From the (Epi)Genome to metabolism and vice Versa; examples from hematologic malignancy . Int J Mol Sci. 2021;22(12):6321. https:\/\/doi.org\/10.3390\/ijms22126321.","journal-title":"Int J Mol Sci"},{"key":"4093_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.molimm.2018.09.011","volume":"103","author":"J Zhang","year":"2018","unstructured":"Zhang J, Han X, Hu X, et al. IDO1 impairs NK cell cytotoxicity by decreasing NKG2D\/NKG2DLs via promoting miR-18a . Mol Immunol. 2018;103:144\u201355. https:\/\/doi.org\/10.1016\/j.molimm.2018.09.011.","journal-title":"Mol Immunol"},{"key":"4093_CR38","doi-asserted-by":"publisher","first-page":"137499","DOI":"10.1016\/j.chemosphere.2022.137499","volume":"313","author":"J Wang","year":"2023","unstructured":"Wang J, Han L, Liu Z, et al. Genus unclassified_Muribaculaceae and microbiota-derived butyrate and indole-3-propionic acid are involved in benzene-induced hematopoietic injury in mice . Chemosphere. 2023;313:137499. https:\/\/doi.org\/10.1016\/j.chemosphere.2022.137499.","journal-title":"Chemosphere"},{"issue":"4","key":"4093_CR39","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-21-0692","volume":"12","author":"M Gal\u00e1n-D\u00edez","year":"2022","unstructured":"Gal\u00e1n-D\u00edez M, BOROT F, ALI A M, et al. Subversion of serotonin receptor signaling in osteoblasts by kynurenine drives acute myeloid leukemia . Cancer Discov. 2022;12(4):1106\u201327. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0692.","journal-title":"Cancer Discov"},{"issue":"11","key":"4093_CR40","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.7150\/thno.55986","volume":"11","author":"S Karmakar","year":"2021","unstructured":"Karmakar S, And Lai G. Role of serotonin receptor signaling in cancer cells and anti-tumor immunity . Theranostics. 2021;11(11):5296\u2013312. https:\/\/doi.org\/10.7150\/thno.55986.","journal-title":"Theranostics"},{"issue":"3","key":"4093_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clml.2018.12.005","volume":"19","author":"RS Komrokji","year":"2019","unstructured":"Komrokji RS, Wei S, Mailloux AW, et al. A phase II study to determine the safety and efficacy of the oral inhibitor of indoleamine 2,3-Dioxygenase (IDO) enzyme INCB024360 in patients with myelodysplastic syndromes . Clin Lymphoma Myeloma Leuk. 2019;19(3):157\u201361. https:\/\/doi.org\/10.1016\/j.clml.2018.12.005.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"4093_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12185-015-1835-8","volume":"102","author":"N Nakamura","year":"2015","unstructured":"Nakamura N, Hara T, SHIMIZU M, et al. Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice . Int J Hematol. 2015;102(3):327\u201334. https:\/\/doi.org\/10.1007\/s12185-015-1835-8.","journal-title":"Int J Hematol"},{"issue":"7","key":"4093_CR43","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41375-024-02266-y","volume":"38","author":"Y Li","year":"2024","unstructured":"Li Y, Chen K, Chen B, et al. Increased coexpression of PD-L1 and IDO1 is associated with poor overall survival in patients with NK\/T-cell lymphoma . Leukemia. 2024;38(7):1553\u201363. https:\/\/doi.org\/10.1038\/s41375-024-02266-y.","journal-title":"Leukemia"},{"issue":"1","key":"4093_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40170-023-00302-6","volume":"11","author":"J Fu","year":"2023","unstructured":"Fu J, Zhang A, Liu Q, et al. Metabolic profiling reveals metabolic features of consolidation therapy in pediatric acute lymphoblastic leukemia . Cancer Metab. 2023;11(1):2. https:\/\/doi.org\/10.1186\/s40170-023-00302-6.","journal-title":"Cancer Metab"},{"issue":"8","key":"4093_CR45","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1016\/j.apsb.2024.04.021","volume":"14","author":"L Cheng","year":"2024","unstructured":"Cheng L, Wang X, Liu A, et al. Phenylalanine deprivation inhibits multiple myeloma progression by perturbing Endoplasmic reticulum homeostasis . Acta Pharm Sin B. 2024;14(8):3493\u2013512. https:\/\/doi.org\/10.1016\/j.apsb.2024.04.021.","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"4093_CR46","doi-asserted-by":"publisher","first-page":"e2104134","DOI":"10.1002\/advs.202104134","volume":"9","author":"C Li","year":"2022","unstructured":"Li C, You X, Xu X, et al. A metabolic reprogramming amino acid polymer as an immunosurveillance activator and leukemia targeting drug carrier for T-Cell acute lymphoblastic leukemia . Adv Sci (Weinh). 2022;9(9):e2104134. https:\/\/doi.org\/10.1002\/advs.202104134.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"4093_CR47","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3760\/cma.j.cn112152-20201212-01066","volume":"44","author":"QL Huang","year":"2022","unstructured":"Huang QL, Zhao RR, Yang BY, et al. [Preliminary exploration of the metabolic profile and metabolic pathways in newly diagnosed multiple myeloma] . Zhonghua Zhong Liu Za Zhi. 2022;44(12):1369\u201375. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20201212-01066.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"6","key":"4093_CR48","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cmet.2023.04.017","volume":"35","author":"J Cheng","year":"2023","unstructured":"Cheng J, Yan J, Liu Y, et al. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8\u2009+\u2009T cells in the tumor microenvironment . Cell Metabol. 2023;35(6):961\u2013e97810. https:\/\/doi.org\/10.1016\/j.cmet.2023.04.017.","journal-title":"Cell Metabol"},{"issue":"1","key":"4093_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1189\/jlb.5A1113-626RR","volume":"97","author":"J Wu","year":"2015","unstructured":"Wu J, Zhang R, Tang N, et al. Dopamine inhibits the function of Gr-1\u2009+\u2009CD115\u2009+\u2009myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity . J Leukoc Biol. 2015;97(1):191\u2013200. https:\/\/doi.org\/10.1189\/jlb.5A1113-626RR.","journal-title":"J Leukoc Biol"},{"key":"4093_CR50","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283471","author":"VS Stanulovi\u0107","year":"2024","unstructured":"Stanulovi\u0107 VS, Al Omair S, Reed MAC, et al. The glutamate\/aspartate transporter EAAT1 is crucial for T-cell acute lymphoblastic leukemia proliferation and survival . Haematologica. 2024. https:\/\/doi.org\/10.3324\/haematol.2023.283471.","journal-title":"Haematologica"},{"issue":"12","key":"4093_CR51","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.3390\/ijms25126543","volume":"25","author":"V Tosello","year":"2024","unstructured":"Tosello V, Di Martino L, Piovan E. Targeted metabolomics of tissue and plasma identifies biomarkers in mice with NOTCH1-Dependent T-Cell acute lymphoblastic leukemia . Int J Mol Sci. 2024;25(12):6543. https:\/\/doi.org\/10.3390\/ijms25126543.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4093_CR52","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/dna.2022.0661","volume":"42","author":"N Liu","year":"2023","unstructured":"Liu N, Liu G, Jiang H, et al. Effect of the Mitogen-Activated protein kinase pathway on the Erastin-Induced ferroptosis of Molt-4 cells . DNA Cell Biol. 2023;42(6):348\u201356. https:\/\/doi.org\/10.1089\/dna.2022.0661.","journal-title":"DNA Cell Biol"},{"issue":"12","key":"4093_CR53","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1021\/acsabm.3c00888","volume":"6","author":"T Yamada","year":"2023","unstructured":"Yamada T, Ishimaru M, Shoji T, et al. Polyoxazoline-Conjugated l-Asparaginase: an antibody-Production-Free therapeutic agent for acute lymphoblastic leukemia . ACS Appl Bio Mater. 2023;6(12):5789\u201397. https:\/\/doi.org\/10.1021\/acsabm.3c00888.","journal-title":"ACS Appl Bio Mater"},{"issue":"19","key":"4093_CR54","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1182\/blood.2022017575","volume":"140","author":"A Cunningham","year":"2022","unstructured":"Cunningham A, Erdem A, Alshamleh I, et al. Dietary methionine starvation impairs acute myeloid leukemia progression . Blood. 2022;140(19):2037\u201352. https:\/\/doi.org\/10.1182\/blood.2022017575.","journal-title":"Blood"},{"key":"4093_CR55","doi-asserted-by":"publisher","first-page":"1056648","DOI":"10.3389\/fnut.2022.1056648","volume":"9","author":"H Zhou","year":"2022","unstructured":"Zhou H, Wang F, Niu T. Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia . Front Nutr. 2022;9:1056648. https:\/\/doi.org\/10.3389\/fnut.2022.1056648.","journal-title":"Front Nutr"},{"issue":"6","key":"4093_CR56","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/biom12060802","volume":"12","author":"M Yang","year":"2022","unstructured":"Yang M, Lu Y, Piao W, et al. The translational regulation in mTOR. Pathw Biomolecules. 2022;12(6):802. https:\/\/doi.org\/10.3390\/biom12060802.","journal-title":"Pathw Biomolecules"},{"issue":"5","key":"4093_CR57","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/1878-0261.12877","volume":"15","author":"TL Nguyen","year":"2021","unstructured":"Nguyen TL, Nokin M-J, TER\u00e9S S, et al. Downregulation of glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia . Mol Oncol. 2021;15(5):1412\u201331. https:\/\/doi.org\/10.1002\/1878-0261.12877.","journal-title":"Mol Oncol"},{"issue":"10","key":"4093_CR58","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.3324\/haematol.2021.280290","volume":"107","author":"X Xu","year":"2022","unstructured":"Xu X, Wang J, Tong T, et al. A self-assembled leucine polymer sensitizes leukemic stem cells to chemotherapy by inhibiting autophagy in acute myeloid leukemia . Haematologica. 2022;107(10):2344\u201355. https:\/\/doi.org\/10.3324\/haematol.2021.280290.","journal-title":"Haematologica"},{"issue":"6","key":"4093_CR59","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/01635581.2024.2337159","volume":"76","author":"Q Chen","year":"2024","unstructured":"Chen Q, Jiang C, Li H. Indole-3-Carbinol promotes apoptosis and inhibits the metastasis of esophageal squamous cell carcinoma by downregulating the Wnt\/\u03b2-Catenin signaling pathway . Nutr Cancer. 2024;76(6):543\u201351. https:\/\/doi.org\/10.1080\/01635581.2024.2337159.","journal-title":"Nutr Cancer"},{"issue":"1","key":"4093_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, et al. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion . Nat Rev Clin Oncol. 2022;19(1):23\u201336. https:\/\/doi.org\/10.1038\/s41571-021-00549-2.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"4093_CR61","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1172\/JCI131859","volume":"130","author":"M-H Oh","year":"2020","unstructured":"Oh M-H, Sun I-H, Zhao L, et al. Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells . J Clin Invest. 2020;130(7):3865\u201384. https:\/\/doi.org\/10.1172\/JCI131859.","journal-title":"J Clin Invest"},{"key":"4093_CR62","doi-asserted-by":"publisher","unstructured":"Cai Y, Chow JPH, Leung Y-O et al. NEI-01-Induced Arginine Deprivation Has Potent Activity Against Acute Myeloid Leukemia Cells Both In Vitro and In Vivo . Mol Cancer Ther, 2021, 20(11): 2218\u20132227. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0120","DOI":"10.1158\/1535-7163.MCT-21-0120"},{"issue":"9","key":"4093_CR63","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1002\/cam4.3871","volume":"10","author":"H-J Tsai","year":"2021","unstructured":"Tsai H-J, Hsiao H-H, Hsu Y-T, et al. Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia . Cancer Med. 2021;10(9):2946\u201355. https:\/\/doi.org\/10.1002\/cam4.3871.","journal-title":"Cancer Med"},{"key":"4093_CR64","doi-asserted-by":"publisher","first-page":"686765","DOI":"10.3389\/fonc.2021.686765","volume":"11","author":"X Lu","year":"2021","unstructured":"Lu X, Han L, Busquets J, et al. The combined treatment with the FLT3-Inhibitor AC220 and the complex I inhibitor IACS-010759 synergistically depletes Wt- and FLT3-Mutated acute myeloid leukemia cells . Front Oncol. 2021;11:686765. https:\/\/doi.org\/10.3389\/fonc.2021.686765.","journal-title":"Front Oncol"},{"key":"4093_CR65","doi-asserted-by":"crossref","unstructured":"Cormerais Y, Vu\u010deti\u0107 M, Parks SK, et al. Amino acid transporters are a vital focal point in the control of mTORC1 signaling and cancer . International journal of molecular sciences; 2020.","DOI":"10.3390\/ijms22010023"},{"issue":"24","key":"4093_CR66","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1182\/bloodadvances.2023010964","volume":"7","author":"B Gomez Solsona","year":"2023","unstructured":"Gomez Solsona B, Horn H, Schmitt A, et al. Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress . Blood Adv. 2023;7(24):7433\u201344. https:\/\/doi.org\/10.1182\/bloodadvances.2023010964.","journal-title":"Blood Adv"},{"key":"4093_CR67","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fbioe.2018.00212","volume":"6","author":"LP Brumano","year":"2018","unstructured":"Brumano LP, Da Silva FVS, Costa-Silva TA, et al. Development of L-Asparaginase biobetters: current research status and review of the desirable quality profiles . Front Bioeng Biotechnol. 2018;6:212. https:\/\/doi.org\/10.3389\/fbioe.2018.00212.","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"4093_CR68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2165\/11632990-000000000-00000","volume":"12","author":"K Minowa","year":"2012","unstructured":"Minowa K, Suzuki M, Fujimura J, et al. L-asparaginase-induced pancreatic injury is associated with an imbalance in plasma amino acid levels . Drugs R D. 2012;12(2):49\u201355. https:\/\/doi.org\/10.2165\/11632990-000000000-00000.","journal-title":"Drugs R D"},{"issue":"1","key":"4093_CR69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13046-023-02845-4","volume":"42","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Yao Y, GE T, et al. Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity . J Exp Clin Cancer Res. 2023;42(1):291. https:\/\/doi.org\/10.1186\/s13046-023-02845-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"4093_CR70","doi-asserted-by":"publisher","unstructured":"Wang M, Zhao A, LI M et al. Amino acids in hematologic malignancies: current status and future perspective . Front Nutr 2023, 10:1113228. https:\/\/doi.org\/10.3389\/fnut.2023.1113228","DOI":"10.3389\/fnut.2023.1113228"},{"issue":"3","key":"4093_CR71","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/cancers14030553","volume":"14","author":"Halama a and suhre k","year":"2022","unstructured":"Halama a and suhre k. Advancing cancer treatment by targeting glutamine Metabolism-A roadmap . Cancers. 2022;14(3):553. https:\/\/doi.org\/10.3390\/cancers14030553.","journal-title":"Cancers"},{"key":"4093_CR72","doi-asserted-by":"publisher","unstructured":"Vogl DT, Younes A, Stewart K, et al. Phase 1 study of CB-839, a first-in-class, glutaminase inhibitor in patients with multiple myeloma and lymphoma . Blood. 2015;126(23). https:\/\/doi.org\/10.1182\/blood.V126.23.3059.3059.","DOI":"10.1182\/blood.V126.23.3059.3059"},{"key":"4093_CR73","doi-asserted-by":"publisher","first-page":"1589943","DOI":"10.3389\/fimmu.2025.1589943","volume":"16","author":"S Chen","year":"2025","unstructured":"Chen S, Zhang Y, Li X, et al. Driving innovations in cancer research through Spatial metabolomics: a bibliometric review of trends and hotspot. Front Immunol. 2025;16:1589943. https:\/\/doi.org\/10.3389\/fimmu.2025.1589943.","journal-title":"Front Immunol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04093-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04093-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04093-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T21:53:26Z","timestamp":1767045206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04093-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4093"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04093-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2284"}}